Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis

被引:12
作者
de Miguel, Rebeca
el-Azhary, Rokea [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
CHRONIC PLAQUE PSORIASIS; CONTINUOUS EFALIZUMAB THERAPY; PLACEBO-CONTROLLED TRIAL; TO-SEVERE PSORIASIS; LONG-TERM TREATMENT; ETANERCEPT TREATMENT; CLINICAL-EXPERIENCE; OPEN-LABEL; COAL-TAR; ADALIMUMAB;
D O I
10.1111/j.1365-4632.2009.04012.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:653 / 658
页数:6
相关论文
共 53 条
[1]   Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy [J].
Andrys, C. ;
Borska, L. ;
Pohl, D. ;
Fiala, Z. ;
Hamakova, K. ;
Krejsek, J. .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 298 (10) :479-483
[2]  
[Anonymous], 2007, J AM ACAD DERMATOL
[3]   The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital [J].
Antoniou, C. ;
Stefanaki, I. ;
Stratigos, A. ;
Avgerinou, G. ;
Stavropoulos, P. ;
Potouridou, I. ;
Polidorou, D. ;
Moustou, A. E. ;
Kosmadaki, M. ;
Katsambas, A. D. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 :12-16
[4]  
Boehncke WH, 2006, J RHEUMATOL, V33, P1447
[5]  
Bos W E M, 2006, Ned Tijdschr Geneeskd, V150, P1065
[6]  
CORT DH, 1980, CUTIS, V25, P201
[7]   Long-term treatment of plaque psoriasis with efalizumab: an Italian experience [J].
Costanzo, A. ;
Peris, K. ;
Talamonti, M. ;
Di Cesare, A. ;
Fargnoli, M. Concetta ;
Botti, E. ;
Chimenti, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 :17-23
[8]   Anti-TNF-α-induced systemic lupus syndrome [J].
Debandt, M ;
Vittecoq, O ;
Descamps, V ;
Le Loët, X ;
Meyer, O .
CLINICAL RHEUMATOLOGY, 2003, 22 (01) :56-61
[9]   Problems encountered during anti-tumour necrosis factor therapy [J].
Desai, Sheetal B. ;
Furst, Daniel E. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (04) :757-790
[10]  
DESGROSEILLIERS JP, 1981, CAN MED ASSOC J, V124, P1018